//
Stockholm-built AI clinical assistant with an MDR Class IIa-marked medical scribe
Review by EuropeanStack EditorialUpdated Verified
Tandem Health puts regulatory status at the centre of its pitch. A Swedish topco, European lead investors, an MDR Class IIa marking, public prices and a usable free tier make a strong case. The weak points are real. Pro is expensive, hosting is described only as "within Europe" with sub-processor details not public, and the move toward a broader clinic platform may dilute focus. Like every ambient scribe, it can mishear a drug name or attach a detail to the wrong person, so clinicians must read and sign off each note before it enters the record.
Tandem Health is a Stockholm-based AI clinical assistant that listens to consultations and drafts notes, referrals and diagnostic codes, then transfers them into the electronic health record. Founded in 2023, it reports more than 10,000 care organisations across 14 European markets and holds an EU MDR Class IIa marking for its scribe.
Headquarters
Stockholm, Sweden
Founded
2023
Pricing
Employees
51-200
Free
€125/mo
Contact Sales
Billing: annual, monthly
Tandem Health is a Stockholm-based AI clinical assistant that listens to consultations and drafts the notes, referrals and diagnostic codes a clinician would otherwise type up afterwards. The legal entity is Tandem Health AB, registered in Sweden under organisation number 559444-6857. It was incorporated in August 2023 by Lukas Saari, Oliver Astrand and Oscar Boldt-Christmas.
The market it enters is crowded and uneven. American vendors such as Abridge dominate hospital sales in the US, while dozens of lightweight scribes have appeared across Europe. Healthwatch England warned in August 2026 that 27 AI scribes in use across the NHS were unregulated. Against that backdrop, Tandem's main argument is regulatory: it says its AI Medical Scribe, Coding Assistant and Clinical Decision Support are each marked as EU MDR Class IIa medical devices.
Scale has followed quickly. Tandem reports more than 10,000 care organisations across 14 European markets, with the UK as its largest. In September 2026 it announced a $100M Series B led by the Scaleup Europe Fund, with Kinnevik, Northzone and other existing investors taking part. Reported total funding is $160M. Press coverage puts headcount near 170, which matches the 51-200 band we use.
Tandem sits in EuropeanStack's Healthcare AI category next to Paris-based Nabla and Copenhagen-based Corti. Nabla is the closest rival. Corti sells developer infrastructure rather than a clinician app.
The core product captures a consultation and generates structured clinical documents, not just a transcript. Output includes visit summaries, referrals and sick notes. Custom templates let a clinic shape the layout, and voice editing allows hands-free corrections afterwards. Tandem says audio is not retained after transcription.
The Coding Assistant suggests ICD-10 and SNOMED codes from the note. Clinical Decision Support answers clinical questions during a visit with source-linked references, so a doctor can check where an answer came from. Both modules carry their own MDR marking, according to Tandem. Marking is a classification of intended use, and it does not remove the need for clinical judgement.
Tandem's homepage cites more than 130 integrations, and its pricing page promises one-click transfer to 100+ medical record systems. The pitch is that nobody copies and pastes a note into the chart. For clinics on a mainstream European system this is the feature that decides adoption, because a scribe that lives outside the record adds a step rather than removing one. Enterprise customers can request custom integrations.
Most scribes start with physicians and stop there. Tandem lists 50+ specialties, including nursing, mental health, physiotherapy, dentistry, pharmacy and veterinary care. Social services are covered too. A veterinary clinic and an NHS GP practice are both plausible buyers, which is unusual in this category.
The Series B messaging describes an "AI-native clinic operating system" rather than a scribe. That ambition is worth watching. A wider platform can bring scheduling and workflow gains, but it also raises the rollout effort and the risk that the core scribe gets less attention than the roadmap.
Pro includes clinician-led support, meaning the people answering questions have worked in care settings. Enterprise adds onboarding, training and rollout, plus priority clinician support. We found no public community forum, and no public developer API. Clinics that want to build their own workflows on top of the scribe will need to talk to sales or look at an infrastructure vendor.
Nabla is the nearest European comparison. It integrates directly with Epic, athenahealth and Oracle Health, and it keeps non-US data in Belgium, but its paid pricing is unpublished and its speech-to-text runs through Azure in the US. Tandem is the more transparent on price and regulatory status, while Nabla has the deeper US EHR story. Abridge targets large US health systems and sits outside most European buying cycles. For a Nordic, UK or Southern European clinic, Tandem and Nabla are the realistic shortlist.
Tandem is unusually open about pricing. The free plan costs nothing and includes unlimited note generation, two custom templates, two co-workers and a limited daily allowance of Pro Actions. That is a bigger free offer than Nabla, whose free tier stops at 30 consultations a month.
Pro costs EUR 125 per user per month on yearly billing. Monthly billing costs more, since the pricing page shows a 15% discount for yearly billing, but the monthly figure was not displayed when we checked. Pro adds unlimited notes, documents and Pro Actions, unlimited templates, one-click transfers and clinician-led support.
Enterprise pricing is tailored. It adds custom record integrations, onboarding and rollout, single sign-on, usage reports, free admin licences and priority support.
EUR 125 per clinician each month is a significant sum. A solo GP or physiotherapist will feel it, while a hospital department that saves an hour of documentation per clinician per day will likely not. Start on Free, measure the time saved, and move to Pro only for the clinicians who hit the limits.
Tandem is a Swedish company, so GDPR applies directly and the contracting entity sits inside the EU. The homepage states that all patient data is processed and stored in data centres within Europe and that no audio recordings are retained. Note the wording: Tandem says Europe, not the EU, and names no cloud provider or region.
The privacy policy widens that gap. It permits transfers to countries outside the EEA, where service providers, group companies or partners are located, under Standard Contractual Clauses. The public trust centre did not render the sub-processor list, so we could not confirm the hosting provider or the language-model provider. For that reason we leave the EU-hosting field blank. Ask for the sub-processor list and the data processing agreement before signing.
On certifications, Tandem reports ISO 13485, ISO 27001, ISO 42001 and ISO 14001. It also lists NHS DSPT and UK Cyber Essentials Plus. These are vendor claims taken from its own site. The MDR Class IIa marking is the strongest differentiator, since it is a regulatory status rather than an audit badge.
NHS and European clinics that need a regulated scribe. If procurement asks about medical device status, Tandem has an answer that many competitors lack.
Small practices and trialists. If you want to test ambient documentation without a contract, the free plan is the easiest way in among the products we cover.
Multi-profession organisations. If your staff includes nurses, physiotherapists, dentists and vets as well as doctors, Tandem's specialty coverage fits better than a physician-only tool.
Budget-sensitive solo clinicians. If EUR 125 a month is too high, stay on Free or compare other options. If you need a developer API rather than a finished app, look at Corti instead.
Tandem Health puts regulatory status at the centre of its pitch. A Swedish topco, European lead investors, an MDR Class IIa marking, public prices and a usable free tier make a strong case. The weak points are real. Pro is expensive, hosting is described only as "within Europe" with sub-processor details not public, and the move toward a broader clinic platform may dilute focus. Like every ambient scribe, it can mishear a drug name or attach a detail to the wrong person, so clinicians must read and sign off each note before it enters the record.
Tandem Health AB is a Swedish company registered in Stockholm and subject to GDPR. The vendor says data is processed and stored in data centres within Europe, not specifically the EU, and that audio is not retained. Its privacy policy allows transfers outside the EEA under Standard Contractual Clauses, so check the data processing agreement.
Tandem has a free plan with unlimited notes, two custom templates and two co-workers. Pro costs EUR 125 per user per month on yearly billing, and Enterprise pricing is tailored. Monthly billing costs more, as yearly billing carries a 15% discount.
Yes. Tandem states that its AI Medical Scribe, Coding Assistant and Clinical Decision Support carry EU MDR Class IIa marking. That distinguishes it from scribes sold as general productivity tools, though clinicians still review every note.
Nabla is a Paris-based scribe with a 30-consultation free tier and unpublished paid pricing. Abridge is a US health-system product. Tandem publishes its prices, offers a larger free tier and holds a medical device marking, but it has a heavier Pro price.
The homepage cites more than 130 integrations, while the pricing page promises one-click transfer to 100+ medical record systems. Custom integrations are available on the Enterprise plan. Check your specific system with the vendor before committing.
Madrid-built clinical voice AI agent that phones patients for follow-up care